GlassScriptPhysician profile
Kevin Patrick Walsh
NPI 1679035414
$2,154.20
in general payments reported to CMS, 2019-2025
20 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $233 · 2023: $764 · 2024: $695 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,920.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $347.43 | 2023 | Mitraclip, Ensite Precision |
| Amgen INC. | $346.94 | 2022-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $266.44 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $171.73 | 2024 | Uptravi, Opsumit |
| Stryker Corporation | $159.62 | 2025 | Clottriever Bold Catheter, Artix Mt, Flowtriever |
| Boston Scientific Corporation | $154.85 | 2023 | Watchman Access System |
| Lexicon Pharmaceuticals, INC. | $127.00 | 2024 | Inpefa |
| Medtronic, INC. | $126.64 | 2025 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $121.54 | 2023 | Camzyos |
| Pfizer INC. | $86.90 | 2024 | |
| Teleflex LLC | $38.83 | 2025 | Orsiro Mission |
| Abiomed | $34.98 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.60 | 2025 | Jardiance |
| Atricure, INC. | $26.58 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Getinge USA Sales, LLC | $26.52 | 2023 | Cardiosave Hybrid, Type B Plug |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $19.99 | 2024 | Assure Wcd |
| Heartflow, INC. | $18.23 | 2024 | |
| Janssen Pharmaceuticals, INC | $18.08 | 2024 | Xarelto |
| Bridgebio Pharma, INC. | $17.94 | 2025 | Attruby |
| Edwards Lifesciences Corporation | $15.36 | 2024 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.